# Mansi Sharma

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mansi-sharma/

## Facts

| Field | Value |
| --- | --- |
| Citations | 365 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 9 |
| i10-index | 8 |
| Last Known Institution | Amity University |
| OpenAlex ID | https://openalex.org/A5100659638 |
| ORCID iD | 0000-0001-9940-8724 |
| Works | 147 |

## Researcher papers

- [Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer](https://scholariq.org/papers/ki-67-labeling-index-as-a-predictor-of-response-to-neoadjuvant-chemotherapy-in/)
- [IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?](https://scholariq.org/papers/ihc-versus-fish-versus-ngs-to-detect-alk-gene-rearrangement-in-nsclc-all/)
- [EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature](https://scholariq.org/papers/eml4-alk-fusion-as-a-resistance-mechanism-to-osimertinib-and-its-successful/)
- [COVID-19 vaccination status in Indian patients with cancer](https://scholariq.org/papers/covid-19-vaccination-status-in-indian-patients-with-cancer/)
- [Biomarker testing in non-small cell lung carcinoma – More is better: A case series](https://scholariq.org/papers/biomarker-testing-in-non-small-cell-lung-carcinoma-more-is-better-a-case-series/)
- [Chloroquine and hydroxychloroquine: Clutching at straws in the time of COVID-19?](https://scholariq.org/papers/chloroquine-and-hydroxychloroquine-clutching-at-straws-in-the-time-of-covid-19/)
- [Enhancing Blood Platelet Counting through Deep Learning Models for Advanced Diagnostics](https://scholariq.org/papers/enhancing-blood-platelet-counting-through-deep-learning-models-for-advanced/)
- [Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital](https://scholariq.org/papers/frequency-of-t790m-mutations-after-progression-on-epidermal-growth-factor/)
- [Retrospective evaluation of PD-L1 expression in tumor tissue of patients with lung carcinoma and correlation with clinical and demographical data from a tertiary care institute of northern India](https://scholariq.org/papers/retrospective-evaluation-of-pd-l1-expression-in-tumor-tissue-of-patients-with/)
- [ALK-driven NSCLC: A narrative review - Part I](https://scholariq.org/papers/alk-driven-nsclc-a-narrative-review-part-i/)
- [P02.02 Pulmonary Rebiopsy is ‘Here to Stay’ in Non-Small Cell Lung Carcinoma (NSCLC) Patients with Progression on Tyrosine Kinase Inhibitors (TKIs)](https://scholariq.org/papers/p02-02-pulmonary-rebiopsy-is-here-to-stay-in-non-small-cell-lung-carcinoma-nsclc/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Advanced Vision and Imaging](https://scholariq.org/topics/advanced-vision-and-imaging/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Amity University](https://scholariq.org/institutions/amity-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.